Evidence map›Paper›PMID 28785825›Full record

ArticleImmunogenetics2018

Functional polymorphisms in rhesus macaque FCGRT and β2-m.

Zhanna Shubin, Yutaka Tagaya, Bhawna Poonia

Open access · greenAbstract read
In one paragraph

Article in Immunogenetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Rhesus Macaques: VNTR Polymorphism of the FCGRT Gene.Bulletin of experimental biology and medicine · 2024
    Article
  3. Article
  4. VNTR2/VNTR3 genotype in theTherapeutic advances in neurological disorders · 2021
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Zhanna ShubinInstitute of Human Virology, University of Maryland, Baltimore, USA.
Yutaka TagayaInstitute of Human Virology, University of Maryland, Baltimore, USA.
Bhawna PooniaInstitute of Human Virology, University of Maryland, Baltimore, USA. bpoonia@ihv.umaryland.edu.
University of Maryland, Baltimore · US

Funding

Genetic Polymorphisms in Rhesus Macaque FcRn and Association with IgG LevelsR03AI110229 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI POONIA, BHAWNA · 2014 to 2015
$154k
NIAID NIH HHS R03 AI110229NIH HHS R03AI110229
6 · The paper itself

Abstract

Rhesus macaque is an important animal model for studies testing interventions like antibody therapeutics; as such knowledge of inter-individual variations in function of genes affecting antibody recycling is important for optimal experimental design. Neonatal Fc receptor (FcRn), a heterodimer composed of FCGRT and β2-m chains, plays critical role in extending catabolic half-life of IgG. We studied genomic polymorphisms in rhesus macaque FcRn and asked if they are functional by assessing correlations with serum IgG or β2-m levels. We tested 75 animals and report the presence of a VNTR polymorphism in promoter of FcRn as well as a single nucleotide polymorphism in the signal peptide of β2-m. A VNTR minor allele was associated with lower levels of serum IgG. This polymorphism may account for inter-animal variation in antibody levels and has relevance for effective design of rhesus macaque studies investigating vaccine-induced antibody responses and passive immunizations.

Indexed as

AllelesAnimalsAntibodiesHistocompatibility Antigens Class IHumansImmunoglobulin GMacaca mulattaMinisatellite RepeatsPolymorphism, Single NucleotidePromoter Regions, GeneticReceptors, FcAntibodiesFc receptor, neonatalHistocompatibility Antigens Class IImmunoglobulin GReceptors, FcFCGRTPolymorphismsRhesusVNTR, ß2-m, FcRn

Identifiers

PMID28785825
PMCPMC5823023
OpenAlexW2744317062

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.